An interventional study of Anthocyans and placebo in Hypertension, sponsored by Ullevaal University Hospital. Completed at 1 site in Norway. Open to male participants aged 35 Years to 50 Years. Per ClinicalTrials.gov, last updated 2011-07-06.
Sponsored by Ullevaal University Hospital · Not applicable, Interventional, and Treatment
Anthocyans modify cardiovascular and sympathetic function
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's enrollment of 27 is below the median of 90 across 4,995 interventional studies indexed under Hypertension.
Browse Hypertension studies →Ullevaal University Hospital is the lead sponsor of 76 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:
Anthocyans
Dietary Supplement: Anthocyans
no effective agent
Dietary Supplement: Anthocyans · Other: placebo
Anthocyans
Systolic bloodpressure and heartrate
This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ullevaal University Hospital